edatrexate has been researched along with Mesothelioma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belani, CP; Green, MR; Herndon, JE; Kindler, HL; Suzuki, Y; Vogelzang, NJ | 1 |
Khokhar, NZ; Rusch, VW; She, Y; Sirotnak, FM | 1 |
1 trial(s) available for edatrexate and Mesothelioma
Article | Year |
---|---|
Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group B.
Topics: Aminopterin; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Humans; Leucovorin; Leukemia; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Survival Rate; Treatment Failure | 1999 |
1 other study(ies) available for edatrexate and Mesothelioma
Article | Year |
---|---|
Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinums.
Topics: Adenosine Triphosphatases; Aminopterin; Animals; Anion Transport Proteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Cycle Proteins; Cell Division; Cisplatin; Drug Design; Fungal Proteins; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Mesothelioma; Methotrexate; Mice; Mice, Nude; Multidrug Resistance-Associated Proteins; Platinum Compounds; Protein Isoforms; Protein Kinases; RNA, Neoplasm; Schizosaccharomyces pombe Proteins; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |